SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago ...Middle East

87% of patients receiving AKANTIOR® in the Phase 3 Trial were medically cured within a median duration of 4 months compared to 55% with the treatment protocols used in real-world clinical practice today. With the AKANTIOR® protocol used in the Phase 3 Trial, 62% of patients achieved full...

Hence then, the article about sifi reports detailed positive results and new data from the completed phase 3 trial of akantior in patients with acanthamoeba keratitis presented at the american academy of ophthalmology annual meeting in chicago was published today ( Thursday 13/10/2022 - 10:09 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago )

Also on site :

• 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
• One of the Most Anticipated Romantasy Books of 2026 Doesn’t Even Have a Title Yet — But Being on the List Isn’t Surprising!
• 1981 Rock Song Became an Anthem About Grief and Resilience